Study of PSMA PET/CT scans for non-prostate cancers
Treatments studied
Part of Cancer clinical trials.
This study looks at how well a special scan (PSMA PET/CT) works for people with cancers other than prostate cancer. If your doctor already scheduled this scan for your care, you may be able to help researchers learn more about its accuracy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of cancer other than prostate cancer.
- Your doctor has ordered a PSMA PET/CT scan as part of your normal care.
- You are 18 years of age or older.
- You are not pregnant.
- You agree to let the researchers use your medical data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of scan called a PSMA PET to see how well different prostate cancer treatments are working. It is for people with advanced prostate cancer who are about to start or change systemic therapy.
This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.
This study looks at a PSMA-targeted PET/CT scan using 68Ga-PSMA-617 for tumors that show a specific marker (PSMA). It’s meant to help confirm or evaluate suspected or known PSMA-expressing tumors in real-life clinical practice.
This Phase 2 study tests an imaging scan called 18F-PSMA PET/CT to find tumors that have a specific marker (PSMA). It may help doctors better locate and evaluate PSMA-positive cancers.
Hear when a new PSMA Positive Tumors or Tumor Tissues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.